Amylyx Pharmaceuticals, Inc. · NASDAQ:AMLX
Klee Justin B. received 60,039 Amylyx Pharmaceuticals, Inc. shares as an award (Form 4)
Traded Aug 18, 2026 · Filed Aug 20, 2026
On Aug 18, 2026, Klee Justin B. (Director, Co-Chief Executive Officer) received 60,039 Amylyx Pharmaceuticals, Inc. shares as an award, leaving 3,643,520 shares. Filed Aug 20, 2026 (Form 4).
- Awarded
- 60,039 shares
- Holding after
- 3,643,520 shares
- Trading plan
- No
- Role
- Director, Co-Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Common Stock | Award | 60,039 | 3,643,520 | Direct |
Source
Related
- Amylyx Pharmaceuticals, Inc.
- Klee Justin B.
- Amylyx Pharmaceuticals, Inc. shareholders
- Form 4 · Klee Justin B. · Sep 14, 2026
- Form 4 · Milne George M Jr · Oct 7, 2026
- Form 4 · Bedrosian Camille L · Sep 14, 2026
- Form 4 · Frates James M · Sep 14, 2026
- Form 4 · Mazzariello Gina · Sep 14, 2026
- Form 4 · Cohen Joshua B · Sep 14, 2026